CN1231598C - Filtering out non essential segment in copying adenovirus of birds, and its gene engineering products - Google Patents

Filtering out non essential segment in copying adenovirus of birds, and its gene engineering products Download PDF

Info

Publication number
CN1231598C
CN1231598C CN 03131899 CN03131899A CN1231598C CN 1231598 C CN1231598 C CN 1231598C CN 03131899 CN03131899 CN 03131899 CN 03131899 A CN03131899 A CN 03131899A CN 1231598 C CN1231598 C CN 1231598C
Authority
CN
China
Prior art keywords
fragment
itr
carrier
virus
egfp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 03131899
Other languages
Chinese (zh)
Other versions
CN1462804A (en
Inventor
秦爱建
何秀苗
刘岳龙
金文杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yangzhou University
Original Assignee
Yangzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yangzhou University filed Critical Yangzhou University
Priority to CN 03131899 priority Critical patent/CN1231598C/en
Publication of CN1462804A publication Critical patent/CN1462804A/en
Application granted granted Critical
Publication of CN1231598C publication Critical patent/CN1231598C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention belongs to the technical field of producing vaccine medicine in the genetic engineering of the pharmaceutical industry of the biotechnology. An aviadenovirus group I separated in China is used as materials; an L fragment, an r fragment and an ITR fragment at the two terminals of the virus genome are amplified by a PCR method and cloned into a pHC cosmid vector; an enhanced green fluorescent protein (eGFP) gene used as a reporter gene is inserted between the r fragment and the ITR fragment designed well to construct a transfer plasmid carrier pFAV-eGFP; then, a chick embryo renal cell infected by a wild virus is transfected for homologous recombination; recombined viruses are sieved to obtain recombined aviadenoviruses expressing enhanced green fluorescent protein. Thus, a site positioned between the r fragment and the ITR fragment at the right terminal of the genome is determined to the nonessential region for virus replication. The nonessential region for virus replication is used as a carrier for researching and developing relevant genetic engineering products.

Description

A kind of preparation method of recombinant fowl adenovirus
Technical field
The invention belongs to the technical field that the genetically engineered in the biological-pharmacy is produced the vaccine medicine.
Background technology
Adenovirus is found in nineteen fifty-three the earliest, owing to they tend to infects epithelial be named as adenovirus (Adenovirus, Adv).Adenovirus is in Adenoviridae (Adenoviridae), and is widely distributed at occurring in nature.Can be divided into two genus according to its morphological structure, immunological characteristic and host range: mastadenovirus (Mastadenovirus) and Aviadenovirus (Aviadenovirus).
Adenovirus is simple in structure, can produce a large amount of viral DNAs in course of infection, is the good model of eukaryotic gene expression regulatory mechanism research, and the adenovirus host range is extensive, and the infection rate height is easy to cultivate and purifying; Insert foreign gene in adenoviral gene group specific region, do not influence virus replication and can make the foreign gene good representation; Adenovirus is used as living vaccine, relatively safety.Present adenoviral gene group structure, the feature of duplicating, transcribing have also been studied quite clearly, particularly success of some adenovirus and animal construction of recombinant adenovirus containing and successful Application clinically thereof make adenovirus more be subjected to general attention as the research of carrier.
Making up adenovirus carrier comprises and foreign DNA is inserted in the adenoviral gene group disappearance E1 district or E3 district when inserting usually.Adenovirus hominis E1 district disappearance virus can be bred in 293 cells, and for the survival of virus, the disappearance in E1 or E3 district does not influence packaging signal.In addition, assisting down of corresponding clone, the disappearance carrier of scleroproein gene also occurred, or even lacked the carrier of all encoding viral genes.Because the replication of adenovirus has stronger kind specificity, therefore, need to make up different types of adenovirus carrier for fear of using unaccommodated carrier.The animal construction of recombinant adenovirus containing is mainly based on the structure of adenovirus hominis carrier.The animal adenovirus major of studying morely at present has ox, dog, mouse, pig etc.Wherein porcine adenovirus 3 types (PAV-3) are applied in clinical for the carrier on basis.Monteil etc. will contain the replication defective adenoviral recon clinical application of pseudorabies virus protective antigen gene in newborn piglet, and the result confirms to produce neutralizing antibody, and not be subjected to female anti-influence, to the protection of piglet for 16 weeks.The recombined porcine adenovirus (rPAV) that Hammond JM etc. will contain swine fever gp55 (E2) with dosage immunity newborn piglet after, also can produce limited provide protection.
The bird adenovirus has 10 serotypes at least, wherein CELO virus (CELO) is the analysis that aviadenovirus 1 type, aviadenovirus 10 types, goose source adenovirus, egg drop syndrome virus etc. have all been finished structure, complete sequence analysis or the important sequence of physical map, lays the foundation for making up bird gland virus expression carrier.Represent the CELO virus of serum I type aviadenovirus to study relatively thoroughly, its genome total length is 43804bp, finished the mensuration work of complete sequence at present.
The homologous recombination technique of utilizations such as Anne-Isabelle Michou virus in E.coli made up the CELO virus vector.Its result of study has identified that one of a series of virus replication required area and right end is duplicated nonessential region, filtered out AIM46 CELO carrier, this carrier is applied to the research and development of bird vaccine, the more important thing is the zone of having identified a trans-acting, provide experiment basis for setting up auxiliary cell line.Equally, therefore also the same with the Ad5 carrier mammalian cell of transduceing of CELO carrier has shown also that development CELO carrier is used for human gene therapy's potentiality.Francois A etc. utilizes the point mutation technology to determine the nonessential region that duplicates of CELO virus, has made up rf CELO virus vector on this basis.The proteic cDNA of this carrier portability coding IBDV, and can use as the vaccine of chicken.Sheppard M etc. place the VP2 gene of IBDV in the downstream of FAV-10 major late promoter (MLP), insert the NotI site (this site is unique) at the right terminal 99.5mu of viral genome place then on genome, be built into genome and do not have disappearance, contained the reorganization FAV-10 virus of foreign gene.This recombinant virus inoculation SPF chicken can produce antibody response, is highly resistant to the infection of IBDV.
Technology contents
The objective of the invention is to research and develop the reproducibility virus live vector that China is suitable for poultry immunity, development genes involved engineered vaccine is in the hope of playing a role aspect the important transmissible disease of control bird.
The present invention is a material with the isolating I group's aviadenovirus of Chinese chicken group, should virus genomic two terminal L fragments and r fragment by PCR method, right ITR fragment amplification comes out, the clone advances in the pHC cosmid vector, and be reporter gene with enhanced green fluorescence protein (eGFP) gene, between the r fragment and ITR fragment that insertion designs, make up transferring plasmid vector pFAV-eGFP, then transfection by wild virus infection chicken embryo kidney cell, carry out homologous recombination, by infinite dilution method recombinant celo virus, obtain to express the recombinant fowl adenovirus of enhanced green fluorescence protein.Thereby determine that the site between right terminal r fragment of genome and ITR fragment is the virus replication nonessential region, and develop the genes involved engineering product as carrier.
The segmental upstream and downstream of above-mentioned amplification gene group left-end point L primer is respectively:
PL1:5’ggggcggccgcgatgatgtataataacct?3’
PL2:5’gggtctagactcacgcgacatgactgtct?3’
The segmental upstream and downstream of the right terminal r of above-mentioned amplification gene group primer is respectively:
Pr1:5’gcgtctagaccagaaccattcttcagccg?3’
PL2:5’gcggaattcgtaccggactgttgtgcgga?3’
The segmental upstream and downstream of the right ITR of above-mentioned amplification gene group primer is respectively:
PITR1:5’gcggaattcacacacggacaacttcaaag?3’
PITR2:5’gcggtcgacgatgatgtataataacctc?3’。
Specific embodiment
1.FAVI amplification and the extraction of viral DNA
Virus stock solution used is carried out inoculating 9 age in days SPF chicken embryos after 100 times of dilutions, and 37 ℃ of hatchings were got allantoic fluid after 6 days, did suitable processing back negative staining, observed morphology of virus, got the allantoic fluid protease K digesting then, and it is standby to extract virus genom DNA according to a conventional method.
2. design of primers
FAVI virus whole genome sequence according to having delivered has designed three pairs of primers, and they are respectively
PL1:5’ggggcggccgcgatgatgtataataacct?3’
PL2:5’gggtctagactcacgcgacatgactgtct?3’
Pr1:5’gcgtctagaccagaaccattcttcagccg?3’
Pr2:5’gcggaat?tcgtaccggactgttgtgcgga?3’
PITR1:5’gcggaattcacacacggacaacttcaaag?3’
PITR2:5’gcggtcgacgatgatgtataataacctc?3’
I group's aviadenovirus genome left-end point L fragment, right terminal r fragment and right ITR fragment increase respectively.
The 3PCR amplification
The viral DNA of getting 0.1 μ g carries out pcr amplification, adopts the PCR system of 50 μ l: DNA, 0.1 μ g, 10 * PCRbuffer, 5 μ l, 25mM MgCl2 3 μ l, 10mM dNTP 1 μ l, each 25pmol of upstream primer and downstream primer, Taq enzyme 0.5U, add sterilization ultrapure water to 50 μ l, and undertaken: 1. 94 ℃ of 5min, 2. 94 ℃ of 1min, 3. 56 ℃ of 1min by following program, 4. 2. 5. 72 ℃ of 2min repeat-4. go on foot 6. 7. 8. end of 4 ℃ of forever of 72 ℃ of 10min of 30 circulations.
4.PCR the recovery of product, connection and order-checking
The PCR product is passed through 0.8% agarose gel electrophoresis, downcut the purpose fragment, and reclaim test kit with sepharose and reclaim purifying, fetch and receive product and be connected more than the 8hr in 4 ℃ with the pGEM-Teasy carrier in 3: 1 ratio, transform DH5 α competence bacterium, by X-Ga1 plate screening hickie, enzyme is cut evaluation, and three segmental positive plasmid pGEM-T-L, pGEM-T-r, pGEM-T-ITR are used for next step clone and order-checking.
5 contain the structure of eGFP gene FAVI transferring plasmid vector
At first with pGEM-T-r EcoRI, the SpeI enzyme is cut, reclaim the r fragment of 2kb, the clone advances in the PHC carrier of cutting with corresponding enzyme enzyme, and then with the ITR fragment among the pGEM-T-ITR with EcoRI, SalI is inserted into and contains in the segmental pHC-FAVI-r carrier of r, obtain carrier pHC-FAVI-r-ITR, the eGFP expression cassette that contains CMV promotor and SV40polyA is inserted in EcoRI site at this carrier, acquisition contains the pHC-FAVI-r-ITR-eGFP transferring plasmid vector of reporter gene, in order to be beneficial to intracellular homologous recombination, also insert the L fragment of FAVI at last at pHC-FAVI-r-ITR-eGFP.
6 contain the structure of eGFP gene recombination FAVI
In the 60mm culture dish, cultivate former generation CEK to forming 80% individual layer, infect CEK, 37 ℃ of effect 2h with 100 TCID50wt-FAVI; Simultaneously, the DMEM that in 2 eppendorf pipes, respectively adds 100 μ l serum-frees, the FAVI transferring plasmid DNA that adds 7-8 μ l Lipofectin and 1.5-4 μ g then respectively, put room temperature 45min, 2 pipes are mixed, room temperature effect 15mins, the DMEM that adds 800 μ l serum-frees, gently this transfection mixed solution is transferred on the CEK that infects FAVI, at 37 ℃, 5%CO2 effect 6h, transfection liquid is removed in suction, add the DMEM that contains 8% calf serum, cultivated 2-3 days, and observed fluorescence every day for 37 ℃ until the recombinant virus fluorescent spot occurring.
The results of 7 fluorocytes and contain going down to posterity of eGFP gene recombination FAVI
(2 * cell culture maintenance medium mixes with 1.6% agar equal-volume, 5ml/dish), treats that agar solidifies back upset culture dish, 37 ℃, 5%CO2 continuation cultivation 24-48hr to cover nutrient agar medium in the culture dish of fluorescence occurring.The cell and the cell colony that occur fluorescence in the nucleus are performed mark under fluorescent microscope, then with suction pipe with its sucking-off, place the 1ml cell culture maintenance medium, after the freeze thawing 3 times, get supernatant, infect CEK on the 24 porocyte culture plates with different extension rates, after waiting fluorescence to occur, carry out fluorescence again and choose spot.

Claims (2)

1, a kind of preparation method of recombinant fowl adenovirus is characterized in that being finished by following steps:
1) be material with the isolating I group's aviadenovirus of Chinese chicken group, by PCR method with virus genomic two ends, be L fragment and r fragment, and right ITR fragment amplification comes out, the clone advances carrier, and insert between the r fragment and right ITR fragment design with reporter gene EGFP, make up transferring plasmid vector;
2) with the aviadenovirus transferring plasmid vector transfection that makes up by wild virus infection chicken embryo kidney cell, carry out homologous recombination, recombinant celo virus;
The segmental upstream and downstream of above-mentioned amplification gene group left-end point L primer is respectively:
PL1:5’ggggcggccgcgatgatgtataataacct?3’
PL2:5’gggtctagactcacgcgacatgactgtct?3’
The segmental upstream and downstream of the right terminal r of above-mentioned amplification gene group primer is respectively:
Pr1:5’gcgtctagaccagaaccattcttcagccg3’
PL2:5’gcggaattcgtaccggactgttgtgcgga?3’
The segmental upstream and downstream of the right ITR of above-mentioned amplification gene group primer is respectively:
PITR1:5’gcggaattcacacacggacaacttcaaag?3’
PITR2:5’gcggtcgacgatgatgtataataacctc?3’。
2, according to the described method of claim 1, it is characterized in that method that carrier cloning in the step 1) makes up transferring plasmid vector is at first the r fragment cloning of 2kb to be advanced in the PHC carrier of cutting with corresponding enzyme enzyme, and then the ITR fragment is inserted into contains in the segmental pHC-FAVI-r carrier of r, obtain carrier pHC-FAVI-r-ITR; The eGFP expression cassette that contains CMV promotor and SV40polyA is inserted in EcoRI site at this carrier, acquisition contains the pHC-FAVI-r-ITR-eGFP transferring plasmid vector of reporter gene, in order to be beneficial to intracellular homologous recombination, also insert the L fragment of FAVI at last at pHC-FAVI-r-ITR-eGFP.
CN 03131899 2003-06-13 2003-06-13 Filtering out non essential segment in copying adenovirus of birds, and its gene engineering products Expired - Fee Related CN1231598C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 03131899 CN1231598C (en) 2003-06-13 2003-06-13 Filtering out non essential segment in copying adenovirus of birds, and its gene engineering products

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 03131899 CN1231598C (en) 2003-06-13 2003-06-13 Filtering out non essential segment in copying adenovirus of birds, and its gene engineering products

Publications (2)

Publication Number Publication Date
CN1462804A CN1462804A (en) 2003-12-24
CN1231598C true CN1231598C (en) 2005-12-14

Family

ID=29748481

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 03131899 Expired - Fee Related CN1231598C (en) 2003-06-13 2003-06-13 Filtering out non essential segment in copying adenovirus of birds, and its gene engineering products

Country Status (1)

Country Link
CN (1) CN1231598C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102680699B (en) * 2011-11-07 2014-09-24 广西壮族自治区兽医研究所 ELISA (enzyme-linked immunosorbent assay) detection method for identifying fowl adenovirus group I (FAVI) infection
CN103060376A (en) * 2012-12-11 2013-04-24 上海实验动物研究中心 Avian adenovirus transfer carrier and preparation method thereof

Also Published As

Publication number Publication date
CN1462804A (en) 2003-12-24

Similar Documents

Publication Publication Date Title
JP6817979B2 (en) Tumor-selective E1A and E1B mutants
Jogler et al. Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species
Wexler et al. Encyclopedia of toxicology
CN103930551B (en) simian adenovirus and hybrid adenoviral vectors
JP4365023B2 (en) Recombinant porcine adenovirus vector
Grizzle et al. First isolation of largemouth bass virus
JP2009254385A (en) Selectively replicating viral vector
Reddy et al. Porcine adenovirus-3 as a helper-dependent expression vector
CN1237209A (en) Herpesvirus saimiri as viral vector
CN105296538A (en) In-fusion cloning method for recombinant baculovirus
CN1231598C (en) Filtering out non essential segment in copying adenovirus of birds, and its gene engineering products
CN1966683B (en) Recombinant adenovirus for expression of novel tumour suppressor gene p53
CN1955301A (en) Henpox virus universal transfer carrier, recombination henpox virus and its preparation method
CN115386556B (en) Gene engineering vaccine for serially expressing gene recombination pseudorabies virus of African swine fever virus P30 and P54 and application thereof
Brazeau et al. Simian varicella virus open reading frame 63/70 expression is required for efficient virus replication in culture
US8119396B2 (en) Recombinant adenoviral vectors and applications thereof
CN103060376A (en) Avian adenovirus transfer carrier and preparation method thereof
Both Xenogenic adenoviral vectors
CN1554766A (en) Pig breeding and respiratory syndrome recombined adenovirus and vaccine
CN109762842B (en) Replicative recombinant human 41-type adenovirus vector system and application thereof
KR20010086357A (en) Recombinant CELO virus and CELO virus DNA
Liu et al. Characterization of the genome of a vaccine strain of canine adenovirus type 1
Wen et al. Construction and immune evaluation of the recombinant duck adenovirus type 3 delivering capsid protein VP1 of the type 1 duck hepatitis virus
WO1997012981A1 (en) Rabies recombinant adenovirus
Tyndall The Integration of Adenovirus Dna During Productive and Abortive Infection

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee